BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 392313)

  • 1. Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. I. Application to genetic toxicological testing.
    Amacher DE; Paillet S; Ray VA
    Mutat Res; 1979 Dec; 64(6):391-406. PubMed ID: 392313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome analysis of small and large L5178Y mouse lymphoma cell colonies: comparison of trifluorothymidine-resistant and unselected cell colonies from mutagen-treated and control cultures.
    Blazak WF; Los FJ; Rudd CJ; Caspary WJ
    Mutat Res; 1989 Oct; 224(2):197-208. PubMed ID: 2507912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of trifluorothymidine-resistant (TFTr) mutants of L5178Y/TK+/- mouse lymphoma cells.
    Moore MM; Clive D; Hozier JC; Howard BE; Batson AG; Turner NT; Sawyer J
    Mutat Res; 1985 Aug; 151(1):161-74. PubMed ID: 3927157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. II. Test validation and interpretation.
    Amacher DE; Paillet SC; Turner GN; Ray VA; Salsburg DS
    Mutat Res; 1980 Aug; 72(3):447-74. PubMed ID: 7453708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidine kinase activity and trifluorothymidine resistance of spontaneous and mutagen-induced L5178Y cells in RPMI 1640 medium.
    Oberly TJ; Bewsey BJ; Probst GS
    Mutat Res; 1986 Jul; 161(2):165-71. PubMed ID: 3088439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific gene mutations in L5178Y cells in culture.
    Clive D; McCuen R; Spector JF; Piper C; Mavournin KH
    Mutat Res; 1983 Jun; 115(2):225-51. PubMed ID: 6855786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ analysis of trifluorothymidine-resistant (TFTr) mutants of L5178Y/TK+/- mouse lymphoma cells.
    Moore MM; Clive D; Howard BE; Batson AG; Turner NT
    Mutat Res; 1985 Aug; 151(1):147-59. PubMed ID: 3927156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation and characterization of the L5178Y/TK+/- mouse lymphoma mutagen assay system.
    Clive D; Johnson KO; Spector JF; Batson AG; Brown MM
    Mutat Res; 1979 Jan; 59(1):61-108. PubMed ID: 372791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of mutations at the tk locus of L5178Y mouse-lymphoma cells induced by ethyl methanesulphonate and mitomycin C.
    Davies MJ; Phillips BJ; Rumsby PC
    Mutat Res; 1993 Dec; 290(2):145-53. PubMed ID: 7694105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome analysis of trifluorothymidine-resistant L5178Y mouse lymphoma cell colonies.
    Blazak WF; Stewart BE; Galperin I; Allen KL; Rudd CJ; Mitchell AD; Caspary WJ
    Environ Mutagen; 1986; 8(2):229-40. PubMed ID: 3084234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utilization of trifluorothymidine (TFT) to select for thymidine kinase-deficient (TK-/-) mutants from L5178Y/TK+/- mouse lymphoma cells.
    Moore-Brown MM; Clive D; Howard BE; Batson AG; Johnson KO
    Mutat Res; 1981 Oct; 85(5):363-78. PubMed ID: 6795499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic analysis of the L5178Y/TK+/- leads to TK-/- mouse lymphoma mutagenesis assay system.
    Hozier J; Sawyer J; Moore M; Howard B; Clive D
    Mutat Res; 1981 Nov; 84(1):169-81. PubMed ID: 7329431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in situ protocol for measuring the expression of chemically-induced mutations in mammalian cells.
    Spencer DL; Hines KC; Caspary WJ
    Mutat Res; 1994 Apr; 312(2):85-97. PubMed ID: 7510835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of the L5178Y TK+/- mouse lymphoma forward mutation assay using 42 chemicals.
    Oberly TJ; Bewsey BJ; Probst GS
    Mutat Res; 1984 Feb; 125(2):291-306. PubMed ID: 6700611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity and clastogenicity of teniposide (VM-26) in L5178Y/TK +/- -3.7.2C mouse lymphoma cells.
    DeMarini DM; Brock KH; Doerr CL; Moore MM
    Mutat Res; 1987 Mar; 187(3):141-9. PubMed ID: 3821767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ascorbate is detectably mutagenic in the L5178Y TK+/- cell mutation assay.
    Amacher DE; Paillet SC
    Cancer Lett; 1981 Nov; 14(2):151-8. PubMed ID: 7317878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trifluorothymidine resistance and colony size in L5178Y/TK +/- cells treated with methyl methanesulfonate.
    Amacher DE; Paillet SC
    J Cell Physiol; 1981 Mar; 106(3):349-60. PubMed ID: 6783669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method to distinguish between the de novo induction of thymidine kinase mutants and the selection of pre-existing thymidine kinase mutants in the mouse lymphoma assay.
    Wang J; Heflich RH; Moore MM
    Mutat Res; 2007 Jan; 626(1-2):185-90. PubMed ID: 17055776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence analysis of tka(-)-1 and tkb(+)-1 alleles in L5178Y tk+/- mouse-lymphoma cells and spontaneous tk-/- mutants.
    Liechty MC; Rauchfuss HS; Lugo MH; Hozier JC
    Mutat Res; 1993 Apr; 286(2):299-307. PubMed ID: 7681542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular aspects of chemical mutagenesis in L5178Y/tk +/- mouse lymphoma cells.
    Clive D; Glover P; Applegate M; Hozier J
    Mutagenesis; 1990 Mar; 5(2):191-7. PubMed ID: 2188074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.